📰 Abstracts News
Page 5 - Abstracts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abstracts. Real-time updates on events, politics, business and more.
April 20, 2023
Nine Imeglimin abstracts to be presented at the 66th Annual Meeting of the Japanese Diabetes Society Regulatory News: POXEL SA (Euronext: POXEL FR0012432516) (Paris:POXEL), a clinical stage
April 18, 2023
Preprints, or research that is not peer reviewed, are becoming increasingly important in medical communication for findings of randomized clinical trials (RCTs).
April 12, 2023
Abstracts include results of innovative home hemodialysis program in Hawaii and gender gap survey focused on female nephrologists ... | April 12, 2023
April 12, 2023
Accepted abstracts include three summarizing findings from separate, large-scale, real-world studies evaluating clinical utility of Decipher Prostate Genomic Classifier ... | April 12, 2023
April 10, 2023
CLEVELAND, April 10, 2023 -- Abeona Therapeutics Inc. today announced the acceptance of three abstracts at the 26th Annual Meeting of the American Society of Gene & Cell Therapy taking... | April 10, 2023
April 6, 2023
FT. MYERS, FL / ACCESSWIRE / April 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that the company and its collaborators
March 24, 2023
- Eisai Co., Ltd. announced today the presentation of two abstracts at the Society of Gynecologic Oncology 2023 Annual Meeting on Womens Cancer , which is taking place in-person in Tampa, Florida... | March 24, 2023
March 6, 2023
Three late-breaking presentations in vitiligo highlight new long-term data from the Phase 3 TRuE-V trials for Opzelura (ruxolitinib) cream and results from a Phase 2b study with povorcitinib (INCB54707)
February 16, 2023
Celebrating 25 years of CEM events, the Scientific committee of CEM The International Conference on Emissions Monitoring is looking for Papers and Posters. Click to read more...
February 1, 2023
Veracyte, Inc. today announced that six abstracts highlighting new data focused on the company’s Decipher urologic cancer testing offerings will be presented at the 2023 ASCO Genitourinary ... | February 1, 2023